Revista nº 814

Endotelio corneal derivado de células madre mesenquimales | Martínez-Castillo R, et al. 288 Actual Med. 2021; 106(814): 280- 290 1. Friedenstein AJ, Chailakhyan RK, Latsinik N V, Panasyuk AF, Keiliss-Borok I V. Stromal cells responsible for trans- ferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Trans- plantation. 1974 Apr;17(4):331–40. DOI:https://doi. org/10.1097/00007890-197404000-00001 2. Wang H-S, Hung S-C, Peng S-T, Huang C-C, Wei H-M, Guo Y-J, et al. Mesenchymal Stem Cells in the Whar- ton’s Jelly of the Human Umbilical Cord. Stem Cells. 2004 Dec;22(7):1330–7. DOI :https://doi.org/10.1634/stem- cells.2004-0013 3. Rodriguez A-M, Elabd C, Amri E-Z, Ailhaud G, Dani C. The human adipose tissue is a source of multipotent stem cells. Biochimie. 2005 Jan;87(1):125–8. DOI:https://doi. org/ 10.1016/j.biochi.2004.11.007 4. Nancarrow-Lei R, Mafi P, Mafi R, Khan W. A Syste- mic Review of Adult Mesenchymal Stem Cell Sources and their Multilineage Differentiation Potential Rele- vant to Musculoskeletal Tissue Repair and Regenera- tion. Curr Stem Cell Res Ther. 2017 Nov;12(8):601–10. DOI :https://doi.org/ 10.2174/1574888X12666170608124 303 5. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med. 2004 Jul-Sep;8(3):301-16. DOI: https://doi.org/10.1111/j.1582-4934.2004.tb00320.x. 6. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Thera- py position statement. Cytotherapy. 2006 Jan;8(4):315-7. DOI: https://doi.org/10.1080/14653240600855905 7. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cor- tenbach I, Marini FC, et al. Clarification of the nomenclatu- re for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393–5. DOI: https://doi.org/10.1080/14653240500319234 8. Peh GSL, Beuerman RW, Colman A, Tan DT, Mehta JS. Human corneal endothelial cell expansion for corneal en- dothelium transplantation: an overview. Transplantation. 2011 Apr 27;91(8):811–9. DOI :https://doi.org/10.1097/ tp.0b013e3182111f01 9. Gain P, Jullienne R, He Z, Aldossary M, Acquart S, Cognas- se F, et al. Global Survey of Corneal Transplantation and Eye Banking. JAMA Ophthalmol. 2016 Feb;134(2):167–73. DOI :https://doi.org/10.1001/jamaophthalmol.2015.4776 10. Wörner CH, Olguín A, Ruíz-García JL, Garzón-Ji- ménez N. Cell pattern in adult human corneal en- dothelium. PLoS One. 2011 May;6(5):e19483. DOI :https://doi.org/10.1371/journal.pone.0019483 11. Bahar I, Kaiserman I, McAllum P, Slomovic A, Rootman D. Comparison of posterior lamellar keratoplasty techni- ques to penetrating keratoplasty. Ophthalmology. 2008 Sep;115(9):1525-33. DOI: https://doi.org /10.1016/j.oph- tha.2008.02.010 12. Joyce NC. Proliferative capacity of corneal endothelial cells. Exp Eye Res. 2012 Feb;95(1):16–23. DOI:https://doi. org/10.1016/j.exer.2011.08.014 13. Polse KA, Brand RJ, Cohen SR, Guillon M. Hypoxic effects on corneal morphology and function. Invest Ophthalmol Vis Sci. 1990 Aug;31(8):1542–54. 14. Eghrari AO, Gottsch JD. Fuchs’ corneal dystrophy. Expert Rev Ophthalmol. 2010 Apr;5(2):147–59. DOI:https://doi. org/10.1586/eop.10.8 15. Duman F, Kosker M, Suri K, Reddy JC, Ma JF, Hammersmi- th KM, et al. Indications and outcomes of corneal trans- plantation in geriatric patients. Am J Ophthalmol. 2013 Sep;156(3):600-607.e2. DOI :https://doi.org/10.1016/j. ajo.2013.04.034 16. Pricopie S, Istrate S, Voinea L, Leasu C, Paun V, Radu C. Pseudophakic bullous keratopathy. Rom J Ophthalmol. 2017 Apr-Jun;61(2):90-4. DOI :https://doi.org/10.22336/ rjo.2017.17 17. Chaurasia S, Price FW, Gunderson L, Price MO. Desce- met’s membrane endothelial keratoplasty: clinical results of single versus triple procedures (combined with cataract surgery). Ophthalmology. 2014 Feb;121(2):454–8. DOI:ht- tps://doi.org/10.1016/j.ophtha.2013.09.032 18. Baydoun L, Tong CM, Tse WW, Chi H, Parker J, Ham L, et al. Endothelial cell density after descemet membra- ne endothelial keratoplasty: 1 to 5-year follow-up. Am J Ophthalmol. 2012 Oct;154(4):762–3. DOI :https://doi.or - g/10.1016/j.ajo.2012.06.025 19. Zavala J, López Jaime GR, Rodríguez Barrientos CA, Val- dez-Garcia J. Corneal endothelium: developmental strate- gies for regeneration. Eye (Lond). 2013 May;27(5):579–88. DOI :https://doi.org/10.1038/eye.2013.15 20. Liu X-W, Zhao J-L. [Transplantation of autologous bone marrow mesenchymal stem cells for the treatment of cor- neal endothelium damages in rabbits]. Zhonghua Yan Ke Za Zhi. 2007 Jun;43(6):540–5. 21. Markov V, Kusumi K, Tadesse MG, William DA, Hall DM, Lounev V, et al. Identification of Cord Blood-Derived Me- senchymal Stem/stromal Cell Populations with Distinct Growth Kinetics, Differentiation Potentials, and Gene Ex- pression Profiles. Stem Cells Dev. 2007 Feb;16(1):53–74. DOI :https://doi.org/10.1089/scd.2006.0660 22. Joyce NC, Harris DL, Markov V, Zhang Z, Saitta B. Poten- tial of human umbilical cord blood mesenchymal stem cells to heal damaged corneal endothelium. Mol Vis. 2012 Mar;18:547-64. REFERENCIAS BIBLIOGRÁFICAS